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Ever since the Garden of Eden, men
have been fascinated by what makes
them different from women. This
interest has focused recent attention
on the sex chromosomes X and Y. In
mammals and Drosophila, males are XY
and females XX. In nematodes, males
are XO (as there is no Y) and her-
maphrodites (or self-fertile females)
are XX. The Y chromosome is relatively
gene poor, so X-chromosome dosage
appears to be critical for sex determi-
nation. But this set-up poses two prob-
lems: how do females deal with
having a double dose of X-linked
genes, and how do males deal with
being  aneuploid for the X chromo-
some? Now, in Journal of Biology [1],
Vaijayanti Gupta and colleagues
describe microarray studies to investi-
gate how gene expression from the X
chromosome or the autosomes is
equilibrated in flies, worms and mice
(see ‘The bottom line’ box for a
summary of the work and the ‘Back-
ground’ box for definitions).
Sex equality
Different species have developed strik-
ingly different strategies to deal with
disparities in the dose of X chromo-
some between males and females: in XX
female mammals, one of the two X
chromosomes is randomly inactivated;
XX hermaphrodite nematodes halve the
expression from each X chromosome;
and male Drosophila double expression
from their single X chromosome in
somatic cells [2,3]. These dosage com-
pensation mechanisms serve to balance
the differences between the number of
copies of X-linked genes in somatic
tissues of the two sexes.
“Although we now know that these
species use different approaches to
achieve dosage compensation, this
amounts mainly to playing differently
with a limited panoply of chromatin-
based modifications,” says Philip
Avner from the Pasteur Institute in
Paris, France. X inactivation in
mammals requires expression of the
Xist gene, which produces a large, non-
coding RNA that coats the inactive X
chromosome [3]. The inactive X is
characterized by DNA methylation,
histone hypoacetylation, late replica-
tion and enrichment in the variant
histone macroH2A. The hypertran-
scription of the Drosophila X chromo-
some in somatic cells is dependent on
the ‘male specific lethal’ (msl) loci,
which encode a histone-modifying
MSL complex that acetylates histone
H4 on lysine 16 (H4 K16) [4].
“Much less attention has been paid
to the question of X/autosome
dosage,” says Avner. “X inactivation
would be expected to lead to halved
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The bottom line  
• Microarray analysis of expression of genes on the Drosophila X
chromosome provides the first evidence for dosage compensation in
germline cells.
• Upregulation of expression from the X chromosome ensures balanced
expression between a single X chromosome and two autosomes.
• Increased expression of the X chromosome occurs in flies, nematodes
and mice.quantities of X-linked gene products
compared to autosomal gene products.
Haploinsufficiency for the entire X
would a priori be expected to be cata-
strophic to the organism and lead to
lethality during early embryonic devel-
opment.”  Haploinsufficiency was the
issue that Gupta and colleagues set out
to address. “There was a lack of evi-
dence for a germline dosage compensa-
tion machinery,” notes Gupta, citing
studies showing that in Drosophila the X
chromosomes are not coated with MSL
complexes or hyperacetylated on
H4 K16 in male germ cells [5] (see the
‘Behind the scenes’ box for more on the
rationale for the work). “Also, Parisi et
al. [6] showed that a subset of riboso-
mal protein-encoding genes are equally
expressed in both testis and ovaries and
we had seen that X;AA and XX;AA
tumors showed very similar gene
expression profiles,” adds Gupta. “I’ve
been thinking about this problem since
I was a graduate student in the late 80s,”
recalls Brian Oliver who heads the
research group at the National Institute
of Diabetes and Digestive and Kidney
Diseases in Bethesda, USA. “Until
microarrays appeared, we didn’t really
see a good way to do a convincing
experiment.”
Testing testes and ovaries
Microarray chips covering virtually
the entire Drosophila genome offered
Oliver’s group the chance to look
simultaneously at thousands of genes
and their response to changing gene
doses. “It would be extremely difficult
to draw meaningful conclusions about
the dosage compensation of an entire
chromosome based on just a handful
of genes,” notes Gupta. They used
genetic tricks to remove the influence
of sex-biased expression and included
many replicate hybridizations for every
sample. “We ensured that the X;AA
and XX;AA matched tissue samples
were compared directly against each
other, by hybridizing to the same
array. By including the loop design, we
could compare any sample in the
design to any other. This increased our
total number of replicates (both direct
and indirect). For example, we have 7
X;AA hs-tra tumors and 17 XX;AA otu
and  Sxl tumors [these are the geno-
types used]. There were 6 comparisons
by direct hybridizations between the
X;AA and XX;AA tumors. But we could
additionally compute 113 X;AA versus
XX;AA tumor comparisons indirectly
((17 x 7) - 6).”
The results were strikingly clear: the
expression ratios between X chromo-
some and autosome genes were tightly
centered on 1-fold, indicating that
dosage compensation occurs in the
germline. Gupta and colleagues per-
formed a large number of controls
using flies with deleted or duplicated
autosomal segments to be sure that
they could detect gene dosage affects
on other chromosomes [1]. “We were
able to detect gene expression changes
for our control autosomal aneuploidy
corresponding to as small as 1.5-fold
gene dose change, which was actually a
more stringent dose difference, com-
pared to the 2-fold dose difference in X
chromosome,” says Gupta.
Not content with their impressive
results in flies, Oliver’s group went on
to reanalyze microarray data from
Caenorhabditis elegans and mice. Their
results led them to a similar conclu-
sion: that the single X chromosomes
of X;AA nematodes and mice were
expressed at similar levels to two
autosomes. Di Nguyen and Christine
Disteche, at the University of Washing-
ton, Seattle, USA, recently reported a
similar study of gene expression in a
range of human and mouse somatic
tissues [7]. They also found that doub-
ling of the global expression level of
the X chromosome leads to dosage
compensation in mammalian somatic
tissues. “Interestingly, X-chromosome
expression levels appear even more
markedly increased in the brain,” com-
ments Avner. “Dare one suggest that
the X chromosome has become spe-
cialized in cognitive function and sex?
Also, although some X-linked genes
are expressed in post-meiotic cells of
the male and female germlines, upreg-
ulation is absent, allowing X/A ratios
to be maintained in an equivalent
fashion to somatic tissues.”
How eXactly do they do it?
“Taken together, these experiments
suggest that, with the development of
heteromorphic sex chromosomes, the
driving and unifying force may have
been to maintain X/autosome levels
within relatively strict limits to avoid
haploinsufficiency, and that mecha-
nisms to ensure dosage compensation
may well have been added in later,”
suggests Avner. “But these results leave
us with the conundrum of how, and
exactly when, upregulation of the
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Background
•  Dosage compensation is a genetic regulatory mechanism that
equalizes the expression of genes on the X chromosome, so that, for
example, they are equally expressed in XY males and in XX females.
•  Males have one fewer X chromosome than they have the other
chromosomes (the autosomes); they are aneuploid with respect to
the X chromosome. The consequence is that all genes on the sex
chromosomes exhibit haploinsufficiency, as they exist in only copy
compared to the two copies of genes present on the autosomes.
Males have a genotype that can be written X;AA, whereas females are
XX;AA.thousand or so genes on the X chro-
mosome is put in place during early
development alongside X-inactivation.
Or alternatively, when and how down-
regulation is achieved specifically in
post-meiotic cells.”
Gupta thinks that studying the
germline X-chromosome gene expres-
sion in other organisms (such as mice
and  C. elegans) using a similar
approach might bring new insights.
Oliver is very keen to get a handle on
the mechanism. “We’ll need to probe
chromatin structure in the germline by
ChIP-chip [chromatin immunoprecipi-
tation] type methods,” he says.  He
cites recent studies investigating how
many of the X-chromosome genes
might be regulated by the MSL complex
[8,9]. “There may be other players
besides the MSLs in the soma,” says
Oliver. “This supports our observation
of MSL-independent dosage compen-
sation in the germline.” But he is also
keeping an open mind about dosage
compensation. He is interested in how
the apparent moderate dosage com-
pensation on the autosomes works
and what this can tell us about general
properties of gene expression net-
works.  “And what is the best reference
for measuring dosage compensation?”
asks Oliver provocatively. “It is still
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Behind the scenes
Journal of Biology asked Vaijayanti Gupta and Brian Oliver about their dosage compensation study.
What prompted you to embark on a study of X-chromosome dosage compensation?
Given that aneuploidy is bad, either germ cells need a mechanism that helps them cope with reduced
X-chromosome expression, or they need a compensation mechanism to equilibrate X-chromosome expression. So,
no matter what we found, it would be important. We undertook detailed analyses of this phenomenon using whole-
genome arrays for comparing gene expression of X;AA and XX;AA tissues and, importantly, using autosomal
aneuploidies as necessary controls, to see if there were expression changes in the absence of specialized
X-chromosome compensation machinery.
How long did the study take and what were the difficult steps you encountered?
First, we had to wait 20 years for the technology to arrive! We took approximately 8 months to complete setting up
crosses, growing flies, dissecting the tissues, and running the microarray hybridization experiments. It took
approximately 10-12 months to complete all the data analyses and statistical tests. Several key steps ensured that
our experiments would give us meaningful data. These included the use of large numbers of genome-wide
microarrays and Drosophila genetics, which allowed us to remove sex-biased expression from X;AA and XX;AA
tissues and compare only dose differences.
What was your initial reaction to the results and how were they received by others?
Needless to say, we were very excited when we saw that by using microarrays we were able to detect dose changes
as small as 1.5-fold on autosomes. This gave us the first indication that we would perhaps be able to draw inferences
about germline dosage compensation conclusively. When we saw that the effects of 2-fold dose differences of the X
chromosome were far less than even 1.5-fold autosomal dose change, we were very excited, since this would be
quite contrary to current ideas about dosage effects in the germline.
The results have been received with a lot of enthusiasm by many people in the field. It is a very old problem, but
with very little experimental evidence. These results should lead to some rethinking about dosage compensation.
Virtually everyone in the field thinks of dosage compensation as operating to equilibrate X chromosome expression
between the sexes.
What are the next steps?
An obvious area of interest is finding what constitutes the germline dosage-compensation mechanism. It does not
involve the MSL complex that functions in the soma. Dosage compensation should be marked by a change in the
modifications of core histone proteins that are bound to the chromosome. So identifying these modifications will be
of key interest. But the mechanism could come from an unexpected direction. We have also studied steady-state
message pools. Anything from chromosome structure to mRNA stability could give the result.possible, as long suggested by Jim
Birchler, that autosomal expression is
down in X;AA individuals. 2X = AA or
X = (AA)/2?” Whether it is indeed the
expression on the X chromosome that
goes up or expression of the auto-
somes that goes down, the mysteries of
the X will continue to fascinate both
sexes for many years to come.
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